Repopulation of cancer cells during therapy: an important cause of treatment failure (Q36167592)

12 August 2017

1 reference

title

Repopulation of cancer cells during therapy: an important cause of treatment failure (English)

1 reference

12 August 2017

2

Ian F Tannock

1 reference

12 August 2017

John J Kim

1

1 reference

PubMed ID

15965493

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

12 August 2017

Nature Reviews Cancer

1 reference

12 August 2017

5

1 reference

12 August 2017

7

1 reference

12 August 2017

516-525

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1650

12 August 2017

0 references

cites work

Tumour stem cells--the evidence and the ambiguity

1 reference

The hazard of accelerated tumor clonogen repopulation during radiotherapy

31 March 2020

1 reference

Post-irradiation proliferation kinetics of a serially transplanted murine adenocarcinoma

31 March 2020

1 reference

Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single doses of X-rays

31 March 2020

1 reference

Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation

31 March 2020

1 reference

Influence of dose per fraction and overall treatment time on the response of pulmonary micrometastases of the R1H-tumour to fractionated irradiation

31 March 2020

1 reference

Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors

31 March 2020

1 reference

Tumour cell repopulation during fractionated radiotherapy: Correlation between flow cytometric and radiobiological data in three murine tumours

31 March 2020

1 reference

Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time, Tpot

31 March 2020

1 reference

Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.

31 March 2020

1 reference

The effects of clamping and reoxygenation on repopulation during fractionated irradiation

31 March 2020

1 reference

Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice

31 March 2020

1 reference

The effect of the overall treatment time of fractionated irradiation on the tumor control probability of a human soft tissue sarcoma xenograft in nude mice

31 March 2020

1 reference

Cell kinetics and repopulation parameters of irradiated xenograft tumours in SCID mice: comparison of two dose-fractionation regimens

31 March 2020

1 reference

Repopulation between radiation fractions in human melanoma xenografts

31 March 2020

1 reference

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

31 March 2020

1 reference

Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions

31 March 2020

1 reference

The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report

31 March 2020

1 reference

Dose fractionation and tumour repopulation in radiotherapy for bladder cancer

31 March 2020

1 reference

The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer

31 March 2020

1 reference

The effect of treatment duration in the local control of cervix cancer

31 March 2020

1 reference

How fast is repopulation of tumor cells during the treatment gap?

31 March 2020

1 reference

Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.)

31 March 2020

1 reference

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

31 March 2020

1 reference

Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients

31 March 2020

1 reference

Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea

31 March 2020

1 reference

Improved treatment of a brain-tumor model. Part 1: Advantages of single- over multiple-dose BCNU schedules

31 March 2020

1 reference

Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide

31 March 2020

1 reference

Tumor resistance to therapy: a genetic or kinetic problem?

31 March 2020

1 reference

Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer

31 March 2020

1 reference

Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot study

31 March 2020

1 reference

The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour

31 March 2020

1 reference

Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked

31 March 2020

1 reference

Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions

31 March 2020

1 reference

Changes in the rate of repopulation during multifraction irradiation of mouse skin

31 March 2020

1 reference

Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice

31 March 2020

1 reference

The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation

31 March 2020

1 reference

Molecular mechanisms of radiation-induced accelerated repopulation

31 March 2020

1 reference

Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells

31 March 2020

1 reference

Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation.

31 March 2020

1 reference

The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells

31 March 2020

1 reference

Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation

31 March 2020

1 reference

Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas

31 March 2020

1 reference

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

31 March 2020

1 reference

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.

31 March 2020

1 reference

Repopulation of tumour cells between cycles of chemotherapy: a neglected factor

31 March 2020

1 reference

Proliferation-associated oxygen consumption and morphology of tumor cells in monolayer and spheroid culture

31 March 2020

1 reference

Distribution and activity of antineoplastic drugs in a tumor model

31 March 2020

1 reference

Delivery of molecular and cellular medicine to solid tumors

31 March 2020

1 reference

Tumor physiology and drug resistance

31 March 2020

1 reference

Microregional effects of gemcitabine in HCT-116 xenografts

31 March 2020

1 reference

Biologic basis for altered fractionation schemes.

31 March 2020

1 reference

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

31 March 2020

1 reference

Conventional and Superfractionated Radiation Therapy in Burkitt's Lymphoma

31 March 2020

1 reference

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

31 March 2020

1 reference

Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration

31 March 2020

1 reference

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.

31 March 2020

1 reference

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

31 March 2020

1 reference

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

31 March 2020

1 reference

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

31 March 2020

1 reference

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

31 March 2020

1 reference

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

31 March 2020

1 reference

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

31 March 2020

1 reference

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.

31 March 2020

1 reference

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

31 March 2020

1 reference

Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?

31 March 2020

1 reference

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

31 March 2020

1 reference

Treatment of cancer with radiation and drugs

31 March 2020

1 reference

Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor

31 March 2020

1 reference

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

31 March 2020

1 reference

A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma

31 March 2020

1 reference

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

31 March 2020

1 reference

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

31 March 2020

1 reference

Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer

31 March 2020

1 reference

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

31 March 2020

1 reference

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

31 March 2020

1 reference

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

31 March 2020

1 reference

The molecular genetics of prostate cancer.

31 March 2020

1 reference

Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1650

1 reference

12 August 2017

1 reference

PubMed ID

15965493